Safety of metformin use in hospitalized acute heart failure patients with diabetes mellitus

Back

HFA Premium Access

Safety of metformin use in hospitalized acute heart failure patients with diabetes mellitus

Session: Rapid Fire 2 - Comorbodities

Topic: Metabolism / Diabetes mellitus

Speaker: Associate Professor J. Park (Seongnam, KR)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Associate Professor Jin Joo Park

Seoul National University Bundang Hospital, Seongnam (Korea (Republic of))

1 presentation

0 follower

9 more presentations in this session

Impact of Iron Deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction.

Speaker: Doctor P. Martens (Genk, BE)

Phase 2 open-label extension (OLE) study of patisiran for the treatment of hereditary ATTR (hATTR) amyloidosis: 24-month safety and efficacy in subgroup of patients with cardiac involvement

Speaker: Professor D. Adams (Le Kremlin-Bicetre Cedex, FR)

Heart failure and inflammation-related biomarkers as predictors of new onset diabetes in the general population

Speaker: Doctor N. Suthahar (Rotterdam, NL)

Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- versus post-capillary pulmonary hypertension.

Speaker: Mr T. Gorter (Groningen, NL)

Definition of iron deficiency based on the gold standard of bone marrow iron staining and treatment effect of ferric carboxymaltose in heart failure patients

Speaker: Mr N. Grote Beverborg (Groningen, NL)

Access the full session

Rapid Fire 2 - Comorbodities

Speakers: Associate Professor J. Park, Doctor P. Martens, Professor D. Adams, Doctor N. Suthahar, Mr T. Gorter...

Access

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources